Compound coenzyme for injection

This product is a complex of various coenzymes and bioactive substances extracted and refined from fresh edible yeast. Among them, coenzyme A, coenzyme I, reduced glutathione and other components are mostly coenzymes of important enzymes in acetylation reaction, redox reaction, transmethylation reaction and energy metabolism in the human body, and play an important role in the metabolism of sugar, protein, fat and energy in the body. They are closely related to glycolysis, tricarboxylic acid cycle, fatty acid β-oxidation, synthesis and decomposition of glycogen, synthesis of acetylcholine, tissue respiration, energy transfer, liver protection and detoxification, and anti-radiation (radiation) effects. Since most biochemical reactions in cells are continuous multi-step reactions or chain reaction rings, the completion of the reaction requires the participation of multiple coenzymes and related active substances. Therefore, the simultaneous existence of these coenzymes can complement and coordinate each other, jointly regulate and ensure the smooth progress of the whole process of body metabolism, and maintain or restore the normal function of cells.

The main ingredients of this product are coenzyme A, coenzyme I, reduced glutathione and other biologically active substances, and its active ingredients are derived from yeast. Excipients: mannitol, calcium gluconate, cysteine hydrochloride.

This product is a white or light yellow freeze-dried block, which should be a light yellow clear liquid after dissolution.

It is used for acute and chronic hepatitis, idiopathic thrombocytopenic purpura, leukocytopenia and thrombocytopenia caused by chemotherapy and radiotherapy; it has a certain auxiliary therapeutic effect on oliguria and uremia caused by coronary artery sclerosis, chronic arteritis, myocardial infarction, and renal insufficiency. This product is a coenzyme for acetylation reaction, redox reaction and energy metabolism in the human body, and plays an important role in the metabolism of sugar, fat and protein in the body. It is suitable for the treatment of acute and chronic hepatitis, idiopathic thrombocytopenic purpura, leukocytopenia caused by chemotherapy and radiotherapy; it can be used as an auxiliary therapeutic drug for oliguria and uremia caused by coronary artery sclerosis, chronic arteritis, myocardial infarction, and renal insufficiency.

Intramuscular injection: 1-2 vials each time, dissolve in 1-2ml 0.9% sodium chloride injection and inject intramuscularly. Intravenous drip: 1-2 vials each time, dilute in 5% glucose injection and inject intravenously. 1-2 times a day or once every other day. For patients with severe wasting diseases and tumors, increase the dosage as appropriate according to the doctor's advice.

Too fast intravenous injection can cause short-term hypotension, dizziness, facial flushing, chest tightness, and shortness of breath.

1. It is contraindicated for those who are allergic to this product. 2. It is contraindicated for pregnant women. 3. It is contraindicated for patients in the early stage of cerebral hemorrhage. 4. It is contraindicated for patients with atrioventricular conduction block.

Precautions during pregnancy and lactation: Contraindicated for use during pregnancy.

Not yet clear

Sealed, store in a cool dark place (avoid light and not exceed 20℃).

Coenzyme A 100 units, coenzyme I 0.1 mg

24 months

Beijing SL Pharmaceutical Co., Ltd.

• Founded in:

  1994-12-24

• Address:

  4th Floor, Building 1, Bitongyuan, No. 69, Fushi Road, Haidian District, Beijing

• Tax NO.:

  91110000102299779W

• Registered Funds:

  1,027.35 million yuan

• Website:

  Log in to view

• Email:

  Log in to view